Correlation Between Esperion Therapeutics and Exicure
Can any of the company-specific risk be diversified away by investing in both Esperion Therapeutics and Exicure at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Esperion Therapeutics and Exicure into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Esperion Therapeutics and Exicure, you can compare the effects of market volatilities on Esperion Therapeutics and Exicure and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Esperion Therapeutics with a short position of Exicure. Check out your portfolio center. Please also check ongoing floating volatility patterns of Esperion Therapeutics and Exicure.
Diversification Opportunities for Esperion Therapeutics and Exicure
0.7 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Esperion and Exicure is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Esperion Therapeutics and Exicure in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Exicure and Esperion Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Esperion Therapeutics are associated (or correlated) with Exicure. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Exicure has no effect on the direction of Esperion Therapeutics i.e., Esperion Therapeutics and Exicure go up and down completely randomly.
Pair Corralation between Esperion Therapeutics and Exicure
Given the investment horizon of 90 days Esperion Therapeutics is expected to generate 3.32 times less return on investment than Exicure. But when comparing it to its historical volatility, Esperion Therapeutics is 2.18 times less risky than Exicure. It trades about 0.04 of its potential returns per unit of risk. Exicure is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 550.00 in Exicure on December 1, 2024 and sell it today you would earn a total of 395.00 from holding Exicure or generate 71.82% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Esperion Therapeutics vs. Exicure
Performance |
| Timeline |
| Esperion Therapeutics |
| Exicure |
Esperion Therapeutics and Exicure Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Esperion Therapeutics and Exicure
The main advantage of trading using opposite Esperion Therapeutics and Exicure positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Esperion Therapeutics position performs unexpectedly, Exicure can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Exicure will offset losses from the drop in Exicure's long position.| Esperion Therapeutics vs. Elanco Animal Health | Esperion Therapeutics vs. SIGA Technologies | Esperion Therapeutics vs. ANI Pharmaceuticals | Esperion Therapeutics vs. Phibro Animal Health |
| Exicure vs. Ikena Oncology | Exicure vs. HCW Biologics | Exicure vs. RenovoRx | Exicure vs. Tempest Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |